HPLC 2023
18/06/23 - 22/06/23
The HPLC symposium series is known as the world leading conference on liquid phase separations and related technologies. Its program covers all aspects of separation sciences in liquid and supercritical fluid phases as well as hyphenation with advanced detection technologies, in particular mass spectrometry. The program will span from fundamentals and theory of chromatographic separations and detection principles, over methodological and technological advances including separation materials, column technologies and instruments, to applications in various fields and quality assurance aspects.
The symposium will feature workshops and tutorials, plenary and keynote lectures from the leading scientists in the field. HPLC 2023 will have a big exhibition and vendor seminars in which attendees can see the latest innovations from the leading vendors in the field.
Join this event and tune in for the presentation from Koen Sandra:
■Short course (18th of June): ‘The role of chromatography and mass spectrometry in protein biopharmaceutical analysis.’
■ Agilent Seminar Lecture (19th of June): ‘Advancements in multidimensional LC-MS for the detailed characterization of monoclonal antibodies.’
■ Keynote lecture (20th of June): ‘Studying structure/function relationships of therapeutic antibodies using LC and MS.’
On the 20th of June Gerd Vanhoenacker will be talking about ‘The benefit of low adsorption HPLC hardware for the analysis of challenging solutes big and small.’
Our RIC science geeks Jelle De Vos , Liesa Verscheure and Shauni Detremmerie will be there as well presenting their poster.
Hit them up with all of your analytical challenges!
Poster Jelle De Vos
P-BIOC40Poster Jelle De Vos
Evaluation of size-exclusion chromatography for the characterization of mRNA.Poster Liesa Verscheure
P-BPHA24Poster Liesa Verscheure
2D-CEX-FcRn-MS to study structure/function relation of mAb charge variants.
Poster Shauni Detremmerie
P-BPHA25Poster Shauni Detremmerie
Fatty acid mediated particle formation in polysorbate containing mAb formulations studied by LC-FMA, LC-MS, light obscuration and MFI.